Trials / Recruiting
RecruitingNCT06562777
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
INvestigating Sex and Gender-Related Differences in Immunotherapy Treatment Effects (INSITE)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- OHSU Knight Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to learn more about symptoms that patients experience while receiving immunotherapy for cancer.
Detailed description
PRIMARY OBJECTIVES: I. Characterize sex differences in patient-reported symptomatic immune-related adverse events. II. Determine the level of discordance between clinician-assessed and patient-reported symptomatic immune-related adverse events according to patient gender. OUTLINE: This is an observational study. Patients complete surveys and have their medical records reviewed on study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-Interventional Study |
Timeline
- Start date
- 2023-09-15
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2024-08-20
- Last updated
- 2025-10-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06562777. Inclusion in this directory is not an endorsement.